How to use the Mounjaro jab correctly

Each Mounjaro KwikPen delivers a single weekly dose via a fine subcutaneous needle — you inject under the skin, not into a vein or muscle.
Treatment begins at 2.5 mg to allow your body to adjust; your prescriber decides if and when you move to a higher strength.
Three injection sites are licensed: the abdomen, the upper thigh, and the outer upper arm — rotating between them reduces the risk of skin reactions at any one spot.
The pen must be stored in the fridge at 2–8 °C; always check the Patient Information Leaflet supplied with your pen for the exact room-temperature window before travelling.

The Mounjaro jab is a once-weekly subcutaneous injection given using a pre-filled KwikPen. Each pen contains four doses, and you administer it yourself by pressing the pen against the skin and holding until the injection is complete. As a prescription-only medicine, the right dose and schedule are decided by a qualified prescriber after a clinical assessment. Mounjaro (tirzepatide) is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above with a weight-related health condition, and understanding exactly how to use it safely makes a real difference to how well your treatment goes.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Everything that affects how you inject safely and comfortably

What does the Mounjaro pen actually look like, and what happens when it arrives?

The KwikPen is a compact auto-injector, roughly the size of a fat marker pen, with a clear inspection window so you can confirm the medicine is present before you use it. Your pen arrives via DPD in plain, unbranded packaging with a tracking link on your phone, no indication of the contents from the outside. Inside the box you will also find the Patient Information Leaflet, which is the authoritative source for every detail specific to your pen, including any updated storage guidance.

Before you do anything else, read that leaflet. It is not boilerplate, it contains information that can differ between dose strengths. The NHS tirzepatide medicines page is a reliable plain-English complement, and our detailed guide to the Mounjaro pen walks through each physical step of the injection process.

One practical point: remove the pen from the fridge around 30 minutes before you plan to inject. A slightly warmer pen is more comfortable at the injection site. Check the liquid through the window, it should be clear or faintly yellow. If it looks cloudy, discoloured, or contains particles, do not use that pen and contact your prescriber or pharmacist.

Where on the body should you inject, and does it matter?

The three licensed sites are the abdomen (belly area, avoiding the two-inch zone directly around the navel), the front and outer thigh, and the outer upper arm. All three are equally effective. What does matter is that you rotate sites, not just between the three areas but within them. Injecting into the same small patch repeatedly can cause lipohypertrophy, a build-up of fatty tissue that slows absorption and blunts the medicine's effect.

A simple system many people use is to treat each site as a clock face and work around it week by week. Site choice explained in full covers the abdomen and arm in more detail, while injecting in the thigh addresses the technique for that specific location.

Clean the skin with an alcohol swab and allow it to dry fully, wet skin can cause a brief sting. Pinch the skin lightly if you have a leaner injection site. Press the pen flat against the skin, press the button, and hold the pen in place until the injection is complete; the window will change colour to confirm delivery. Alcohol swabs are available if you need to restock between deliveries.

What should you do immediately after the injection?

Remove the pen from your skin once the indicator confirms the dose has been delivered. Do not rub the injection site, it will not help absorption and may cause mild irritation. A small amount of redness or a faint bruise at the site is common and almost always resolves within a day or two.

Used pens are sharps and must be disposed of in an approved sharps container, not in household recycling or a standard bin. Your local council's website will tell you how to arrange collection or drop-off. Never recap a used needle; the cap is for transport before injection, not after.

It is sensible to keep a simple log, the date, which site you used, and which dose. If you are ever asked by a prescriber or pharmacist about your injection history, having that record is genuinely useful. Some people set a weekly phone reminder to keep their injection day consistent; stable timing is easier on the gut and helps you remember. Our injection technique guidance covers this routine in more depth.

What are the most common side effects to be aware of after injecting?

Gastrointestinal effects are the most frequently reported: nausea, loose stools, constipation, reflux and burping tend to be most noticeable in the days following a new dose or a dose increase, and generally ease within a week or two as the body adjusts. Eating smaller portions, avoiding fatty or rich food around injection day, and staying well hydrated all help. Fatigue and mild headache are also reported, particularly in the first few weeks.

According to the NHS medicines page for tirzepatide, you should seek urgent medical help for severe or persistent stomach pain that radiates to the back, this can indicate pancreatitis, which, while uncommon, requires prompt attention. The MHRA reinforced this with a specific Drug Safety Update in January 2026. Gallbladder symptoms, signs of a serious allergic reaction, or significant dehydration from persistent vomiting or diarrhoea are also reasons to contact a healthcare professional promptly rather than wait.

If side effects are interfering significantly with daily life, speak to your prescriber before adjusting anything. Questions about your particular situation are best handled by a clinician who knows your history. You can also report suspected side effects directly via the MHRA Yellow Card scheme. For a broader look at what to expect from Mounjaro treatment, including how the injection fits into the overall programme, that page covers the wider clinical picture. If you are weighing up the cost of private treatment alongside other considerations, our pricing overview sets out what is included transparently.

A clinician who knows your medical picture is always the right first call for anything that concerns you. Speak to our prescribers if you would like a clinical assessment and the chance to ask questions before you start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions